Search Results 51-60 of 16786 for Fibronolytic
The purpose of this follow-up study is to assess the tolerability, long-term safety, and effectiveness of BI 1015550 in patients with IPF and PPF over a longer ...
Antiplatelet, anticoagulant, and fibrinolytic drugs. In: Harrison's Principles of Internal Medicine. 21st ed. McGraw Hill; 2022. https://accessmedicine ...
About this study. The first double-blind 72-week treatment period will assess the efficacy and safety of elafibranor on the resolution of NASH without ...
Approach to thrombolytic (fibrinolytic) therapy in acute pulmonary embolism: Patient selection and administration. https://www.uptodate.com/contents/search ...
Ponatinib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Participation eligibility. Participant ...
The purpose of this study is to determine the safety and effectiveness of IPI-926 for the treatment of patients who have myelofibrosis, including primary ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The natural course of autosomal dominant polycystic kidney disease (ADPKD) is highly variable and typically characterized by progressive enlargement of cysts ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.